Aktie A000220 YUYU PHARMA, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Yuyu Pharma, Inc.

Aktien

A000220

KR7000220004

A000220

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 14.05.2024 		% 5 Tage % 1. Jan.
4 725 KRW +1,29 % Intraday Chart für Yuyu Pharma, Inc. +0,11 % -10,51 %
20.03. Yuyu Pharma, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 Yuyu Pharma, Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Yuyu Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Yuyu Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Yuyu Pharma to attend 'CPHI Worldwide 2023'
Yuyu Pharma, Inc. announced that it has received KRW 24.5 billion in funding from a group of investors
Yuyu Pharma, Inc. announced that it expects to receive KRW 24.5 billion in funding from a group of investors
Yuyu Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Yuyu Pharma Unveils the Results of Its Mechanism of Action and Head-To- Head Studies for Its Dry Eye Treatment Peptide
Yuyu Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Tranche Update on Yuyu Pharma, Inc.'s Equity Buyback Plan announced on September 19, 2022.
Tranche Update on Yuyu Pharma, Inc.'s Equity Buyback Plan announced on September 19, 2022.
Yuyu Pharma, Inc.'s Equity Buyback announced on September 19, 2022, has closed with 304,878 shares, representing 1.83% for KRW 1,785.24 million.
Yuyu Pharma, Inc. announces an Equity Buyback for 304,878 shares.
Yuyu Pharma, Inc. authorizes a Buyback Plan.
Yuyu Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Yuyu Pharma Announces First Patient Enrolled in Phase 2 Clinical Study Evaluating YP-P10 Ophthalmic Solution for the Treatment of Dry Eye Disease
Yuyu Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Yuyu Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
Yuyu Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Bourse Zurich: le SMI termine dans le vert, un peu sous les 12'200 points
Bourse Zurich: le SMI toujours en hausse à l'approche de la mi-journée
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A000220 Aktie
  4. Nachrichten Yuyu Pharma, Inc.
  5. Andere Sprachen